Skip to main content
Peiman Hematti, MD, Oncology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

PeimanHemattiMD

Oncology • Milwaukee, WI

Hematologic Oncology

Professor of Medicine, Director, Cell Therapy Laboratory

Join to view full profile

Dr. Hematti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hematti's full profile

Already have an account?

Summary

  • Dr. Peiman Hematti is Director of Cell Therapy Lab at Froedtert Hospital and Medical College of Wisconsin. He received his medical degree from Tehran University of Medical Sciences School of Medicine and has been in practice 20 years. He has close to 200 publications, more than a dozen book chapters and several patents.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine/Pediatrics, 1995 - 1999
  • Tehran University of Medical Sciences School of Medicine
    Tehran University of Medical Sciences School of MedicineClass of 1990

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2004 - 2025
  • OH State Medical License
    OH State Medical License 1999 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Pediatrics Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Human Corneal Mesenchymal Stromal Cell-Derived Exosomes on Corneal Epithelial Wound Healing  
    Peiman Hematti, Medi Eslani, Ravand Samaeekia, Investigative Ophthalmology and Visual Science
  • Bioengineering Solutions for Manufacturing Challenges in CAR T Cells  
    Peiman Hematti, Christian M Capitini, Biotechnology Journal

Abstracts/Posters

  • Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination
    Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)
    Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
    Peiman Hematti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • UW Health 1st in US to Treat Heart Disease Patient with Cell Therapy
    UW Health 1st in US to Treat Heart Disease Patient with Cell TherapyNovember 1st, 2021
  • Exosome-Educated Macrophages Show Potential to Treat Ligament Injuries
    Exosome-Educated Macrophages Show Potential to Treat Ligament InjuriesNovember 4th, 2020
  • Therapeutic Plasma Exchange: A Potential Management Strategy for Critically Ill COVID-19 Patients
    Therapeutic Plasma Exchange: A Potential Management Strategy for Critically Ill COVID-19 PatientsJuly 15th, 2020
  • Join now to see all

Grant Support

  • Exosome educated monocytes for acute radiation syndrome MPI with Christian CapitiniNIH/NHLBI2021–2026
  • Embryonic Stem Cell Derived HSC Transplantation In Rhesus Macaque ModelNational Heart, Lung, And Blood Institute2007–2011
  • Rhesus Macaque Hematopoietic Stem Cell ExpansionNational Center For Research Resources2005–2006

Professional Memberships

  • American Society of Hematology - ASH
    Member
  • American Society of Clinical Oncology - ASCO
    Member
  • American Medical Association - AMA
    Member
  • American Society for Transplantation and Cellular Therapy
    Member
  • International Society for Experimental Hematology
    Member
  • American Society of Gene Therapy
    Member
  • International Society for Stem Cell Research
    Member
  • International Society for Cellular Therapy
    Member
  • American Association of Blood Banks
    Member
  • American Society of Transplantation
    Member
  • American Association of Immunologists
    Member
  • Biomedical Engineering Society
    Member
  • Society for Immunotherapy of Cancer
    Member

Other Languages

  • Spanish

Hospital Affiliations

Dr. Peiman Hematti, Dr. Peiman Hematti, MD, Dr. P Hematti